Go Symbol Lookup
Loading...

Analysts Speak on Today’s Market

 Text Size  
Published: Monday, 4 Jun 2007 | 3:54 PM ET
By: By CNBC.com

Here's what analysts had to say today about the market on CNBC:

Wal-Mart: Everybody's Buying?
Analysts may be expecting too much from Wal-Mart's stock, with Mark Husson, HSBC Securities retail analyst; Richard Hastings, Bernard Sands sr. retail analyst and CNBC's Erin Burnett

Wal-Mart: Everybody's Buying?
Analysts may be expecting too much from Wal-Mart's stock, with Mark Husson, HSBC Securities retail analyst; Richard Hastings, Bernard Sands sr. retail analyst and CNBC's Erin Burnett.
2:20 PM [04:00]

Story: Wal-Mart Shares Rise on Analysts' Upgrades

Detailed Quote:Wal-Mart

The Smart Money: Clothing
When celebrities are thrust into the spotlight, certain clothing stocks tend to get a lot of attention, with Jeff Mintz, Wedbush Morgan Securities clothing & accessories analyst and CNBC's Bill Griffeth

The Smart Money: Clothing
When celebrities are thrust into the spotlight, certain clothing stocks tend to get a lot of attention, with Jeff Mintz, Wedbush Morgan Securities clothing & accessories analyst and CNBC's Bill Griffeth.
1:32 PM [03:02]

Dems & Healthcare
Looking for Wall Street's reaction to last night's Democratic debate and the candidates' plans for healthcare, with Andy Laperriere, ISI Group managing director & political analyst; John Harwood, CNBC chief Washington correspondent and CNBC's Bill Griffeth

Dems & Healthcare
Looking for Wall Street's reaction to last night's Democratic debate and the candidates' plans for healthcare, with Andy Laperriere, ISI Group managing director & political analyst; John Harwood, CNBC chief Washington correspondent and CNBC's Bill Griffeth.
12:42 PM [05:13]

ASCO Update
Highlights from the ASCO conference in Chicago, with Mike Huckman, CNBC pharmaceuticals reporter; Christopher Raymond, Robert W. Baird & Co. biotech analyst and CNBC's Sue Herera

ASCO Update
Highlights from the ASCO conference in Chicago, with Mike Huckman, CNBC pharmaceuticals reporter; Christopher Raymond, Robert W. Baird & Co. biotech analyst and CNBC's Sue Herera.
12:31 PM [07:18]

Story:Selling Hope: The Cost Of Curing Cancer

 Print
See what analysts had to say today about the market on CNBC.

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

U.S. Video

  • Eugene Profit, a former NFL cornerback, has a game plan for investing. Now as CEO of Profit Investment Management, he says, "you have to do your job and no excuses."

  • All the taper talk from the Fed is giving the markets a dose of volatility, with Mark Zandi, Moody's Analytics, and Neil Irwin, Washington Post, discuss.

  • The Jersey Shore is ready to welcome tourists for the summer, with CNBC's Kayla Tausche.